MSC-sourced IDO and NO were mainly responsible for the pro-tumorigenic effects of MSCs, since the pharmacological inhibition of IDO and iNOS activity completely abrogated the MSC-driven suppression of anti-tumor immunity in tumor-bearing mice [29]. Here, IDO1 is linked to neoplasm.